These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2343778)

  • 1. In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.
    Grauer A; Raue F; Schneider HG; Frank-Raue K; Ziegler R
    J Bone Miner Res; 1990 Apr; 5(4):387-91. PubMed ID: 2343778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F; Muff R; Dotti-Sigrist S; Dambacher MA; Fischer JA
    J Clin Endocrinol Metab; 1988 Sep; 67(3):541-5. PubMed ID: 3410939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
    Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies against calcitonin.
    Grauer A; Reinel HH; Ziegler R; Raue F
    Horm Metab Res; 1993 Sep; 25(9):486-8. PubMed ID: 8225203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis.
    Muff R; Dambacher MA; Fischer JA
    Osteoporos Int; 1991 Feb; 1(2):72-5. PubMed ID: 1790395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG; Caldwell JG
    J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of antibodies against calcitonin.
    Grauer A; Ziegler R; Raue F
    Exp Clin Endocrinol Diabetes; 1995; 103(6):345-51. PubMed ID: 8788305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
    Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of neutralizing antibodies after treatment with human calcitonin.
    Grauer A; Reinel HH; Lunghall S; Lindh E; Ziegler R; Raue F
    Am J Med; 1993 Oct; 95(4):439-42. PubMed ID: 8213878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neutralizing antibodies against salmon calcitonin. The cause of a treatment failure in Paget's disease].
    Grauer A; Frank-Raue K; Schroth J; Raue F; Ziegler R
    Dtsch Med Wochenschr; 1994 Apr; 119(14):507-10. PubMed ID: 8156882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies].
    Reginster JY; Almer S; Gaspar S; Albert A; Deroisy R; Franchimont P
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):563-7. PubMed ID: 2756322
    [No Abstract]   [Full Text] [Related]  

  • 12. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY; Gennari C; Mautalen C; Deroisy R; Denis D; Lecart MP; Vandalem JL; Collette J; Franchimont P
    Scand J Rheumatol; 1990; 19(1):83-6. PubMed ID: 2309107
    [No Abstract]   [Full Text] [Related]  

  • 14. Intranasal salmon calcitonin treatment of Paget's disease of bone. Results in nine patients.
    D'Agostino HR; Barnett CA; Zielinski XJ; Gordan GS
    Clin Orthop Relat Res; 1988 May; (230):223-8. PubMed ID: 3365896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Paget's disease of bone with salmon calcitonin nasal spray.
    Gagel RF; Logan C; Mallette LE
    J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.
    Singer FR; Fredericks RS; Minkin C
    Arthritis Rheum; 1980 Oct; 23(10):1148-54. PubMed ID: 7000081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional significance of antibody formation after long-term salmon calcitonin therapy.
    Hosking DJ; Denton LB; Cadge B; Martin TJ
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):243-52. PubMed ID: 572275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment.
    Woodhouse NJ; Mohamedally SM; Saed-Nejad F; Martin TJ
    Br Med J; 1977 Oct; 2(6092):927-9. PubMed ID: 410477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.